FindTrial
Sign In

A prospective study to evaluate liver function and lipid profile of intrauterine growth retarded preterm newborn babies of less than 37 weeks of gestation

Evaluation of Liver function and lipid profile of intrauterine growth retarded Preterm Neonates of less than 37 weeks of gestation -A prospective observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027554
Enrollment
100
Registered
2020-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P051- Newborn small for gestational age

Interventions

None listed

Sponsors

Dr Janaki Ballav Pradhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All neonates less than 37 weeks of gestation with birth percentile <10th centile in postnatal growth chart (intergrowth 21)

Exclusion criteria

Exclusion criteria: 1. Neonates with major anomaly 2. Neonates with moderate to severe birth asphyxia 3. Neonates with primary liver disorders

Design outcomes

Primary

MeasureTime frame
1.To compare the liver function test and lipid profile of preterm IUGR neonates of less than 37 weeks of gestation with appropriate for age neonates. 2.To correlate the liver function abnormality and abnormal lipid profile with subsequent physical growth during stay in NICU. Timepoint: Day 0 and 1 year—

Secondary

MeasureTime frame
To measure the all cause morbidity and all cause mortality in IUGR neonates of less than 37 weeks of gestation with appropriate for age neonates.Timepoint: Day 0 and 1 year—

Countries

India

Contacts

Public ContactDr Janaki Ballav Pradhan

Kainga Institute of Medical Sciences Bhubaneswar

pradhan.janakiballav@gmail.com9486559405

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026